Bertis Inc

Bertis Inc. is a South Korea-based proteomics and molecular diagnostics company founded in 2014.

Headquartered in Gwacheon-si, Gyeonggi-do, with bio-manufacturing operations in Yongin-si, Bertis focuses on discovering cancer-related biomarkers for early disease detection and precision medicine. The company is recognized as a leading proteomics firm in Asia. Bertis specializes in proteomics-based precision medicine technologies and AI-based diagnostic platforms for cancer and cardiovascular diseases. Its product offerings include MASTOCHECK, a blood test for early breast cancer detection, a cardiovascular disease marker test for heart disease biomarkers, and PASS, a pan-omics analysis solution for biopharmaceutical research. The company aims to enhance healthcare outcomes through earlier diagnosis and personalized treatment approaches, serving the B2B healthcare, biotechnology, high-tech, and life sciences markets.